Using Mobile Phones to Improve Adherence to Inhaled Steroids (ADEPT4)
This study has two main goals. The first goal is to test whether a mobile phone intervention can increase adherence to daily inhaled steroid medications in African American adolescents prescribed this type of medication by his/her asthma doctor. The second goal is to use a mobile phone intervention to better understand real life patterns of use of quick-relief (beta2-adrenergic agonist) asthma medication in this population.
Behavioral: Coping Peer Support
Behavioral: Coping Peer Asthma Messages
Behavioral: Asthma Supervision
Behavioral: Music Tracks
Behavioral: Mobile Phone
Behavioral: Inhaled Corticosteroid Mobile Phone Application
Behavioral: Beta2-adrenergic agonist Mobile Phone Application
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Refined ADEPT: Human Augmentics for Sustained Wellbeing|
- Adherence to inhaled corticosteroids, measured objectively using an electronic dose counter [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]Adherence is measured as the mean of daily adherence to prescription inhaled corticosteroid dose over 14 days both at baseline and at week 10 of the active treatment phase. For the primary outcome, we will compare adherence at week 10 to adherence at baseline.
- To understand patterns of use of quick-relief medication for asthma [ Time Frame: 10 weeks ] [ Designated as safety issue: No ]This study will use an electronic dose counter and mobile phone technology to track participants real time use of quick-relief (beta2-adrenergic agonist) medication for asthma during the 10 weeks of active treatment.
|Study Start Date:||December 2012|
|Estimated Study Completion Date:||July 2013|
|Estimated Primary Completion Date:||July 2013 (Final data collection date for primary outcome measure)|
Experimental: Experimental: Intervention Group
Experimental: Intervention Group
1) Coping Peer Support delivered over a 10-week time period; 2) Coping Peer Asthma Messages delivered over a 10-week time period; 3) Asthma Supervision; 4) Music Tracks; 5) Mobile Phone with talking, texting, and data plan; 6) Inhaled Corticosteroid Mobile Phone Application to provide virtual doctor supervision, immediate feedback, and positive reinforcement for taking inhaled corticosteroid medication as indicated; and 7) Beta2-adrenergic agonist Mobile Phone Application to monitor real time patterns of use of beta2-adrenergic agonist medication for asthma.
Behavioral: Coping Peer Support
Coping Peer Support will be delivered at weekly group sessions over the 10-week active treatment period. This intervention consists of: group support, group problem solving, and recording of Coping Peer Asthma Messages.Behavioral: Coping Peer Asthma Messages
Study participants will develop and record Coping Peer Asthma Messages at their weekly Coping Peer Group asthma meetings during the 10-week active treatment period. These Coping Peer Asthma Messages will be placed on the participants' mobile phones, and played between their favorite music tracks, as they go about their daily routines. This brings the Coping Peer Support from the weekly Coping Peer Support sessions into their daily lives.Behavioral: Asthma Supervision
Each participant will be provided with a spacer and a peak flow meter, and instructions on proper technique, by a member of the study team during the baseline period.Behavioral: Music Tracks
Study participants receive clean (radio-edited) music tracks during the 10-week active treatment period.Behavioral: Mobile Phone
Each participant will receive a mobile phone with talking, texting and a data plan. They will get to keep the mobile phone at the end of the study, but the talking, texting and data plan will only be active during their participation in the study.Behavioral: Inhaled Corticosteroid Mobile Phone Application
The Inhaled Corticosteroid Mobile Phone Application will be used to provide virtual doctor supervision, immediate feedback, and positive reinforcement for taking inhaled corticosteroid medication as indicated.Behavioral: Beta2-adrenergic agonist Mobile Phone Application
The Beta2-adrenergic agonist Mobile Phone Application will be used to track real time patterns of use of beta2-adrenergic agonist medication.
|Contact: Giselle S. Mosnaim, MD, MSfirstname.lastname@example.org|
|United States, Illinois|
|Rush University Medical Center||Not yet recruiting|
|Chicago, Illinois, United States, 60612|
|Contact: Giselle S. Mosnaim, MD, MS 312-942-8571 email@example.com|
|Principal Investigator: Giselle S. Mosnaim, MD, MS|
|Principal Investigator:||Giselle S. Mosnaim, MD, MS||Rush University Medical Center|